Amit Gupta Sells 68,260 Shares of Cardlytics (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 68,260 shares of Cardlytics stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $1.12, for a total value of $76,451.20. Following the completion of the sale, the chief executive officer directly owned 560,444 shares in the company, valued at $627,697.28. This trade represents a 10.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Amit Gupta also recently made the following trade(s):

• On Tuesday, August 19th, Amit Gupta sold 68,685 shares of Cardlytics stock. The stock was sold at an average price of $1.12, for a total value of $76,927.20.
• On Wednesday, July 2nd, Amit Gupta sold 6,725 shares of Cardlytics stock. The stock was sold at an average price of $1.78, for a total value of $11,970.50.

Cardlytics Trading Down 3.8%

Shares of CDLX stock opened at $1.01 on Friday. The stock’s 50-day moving average price is $1.75 and its 200-day moving average price is $1.98. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 2.87. Cardlytics, Inc. has a 12-month low of $0.95 and a 12-month high of $5.2450. The stock has a market capitalization of $53.77 million, a price-to-earnings ratio of -0.28 and a beta of 1.26.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CDLX. Evercore ISI reduced their price objective on Cardlytics from $3.00 to $2.00 and set an “in-line” rating on the stock in a research note on Friday, August 8th. Lake Street Capital reduced their price objective on Cardlytics from $3.00 to $2.50 and set a “hold” rating on the stock in a research note on Thursday, May 8th. One analyst has rated the stock with a Strong Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $2.25.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Jane Street Group LLC grew its stake in shares of Cardlytics by 263.0% during the second quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock valued at $267,000 after buying an additional 117,687 shares during the last quarter. Sand Hill Global Advisors LLC bought a new position in shares of Cardlytics during the second quarter valued at approximately $35,000. Marshall Wace LLP bought a new position in shares of Cardlytics during the second quarter valued at approximately $59,000. XTX Topco Ltd grew its stake in shares of Cardlytics by 143.5% during the second quarter. XTX Topco Ltd now owns 85,971 shares of the company’s stock valued at $141,000 after buying an additional 50,663 shares during the last quarter. Finally, Catalyst Funds Management Pty Ltd bought a new position in shares of Cardlytics during the second quarter valued at approximately $32,000. Institutional investors own 68.10% of the company’s stock.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.